{"id":4396,"date":"2023-03-17T08:43:05","date_gmt":"2023-03-17T08:43:05","guid":{"rendered":"https:\/\/www.eurocytology.eu\/course\/4396-2\/"},"modified":"2023-04-24T08:39:44","modified_gmt":"2023-04-24T08:39:44","slug":"references-4","status":"publish","type":"course","link":"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/","title":{"rendered":"References"},"content":{"rendered":"
Bookmark (0<\/i>)<\/span><\/a>
<\/a>

Please login to bookmark<\/h3>

\n\t\t\t\t

\n\t\t\t\t

\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/p><\/form>

No account yet? Register<\/a><\/p><\/div><\/div><\/div>

Andrae B, Andersson T M-L, Lambert PC et al<\/em>. (2012). Screening and cervical cancer cures: population based cohort study. BMJ<\/em>  e900. Doi: 10.1136\/bmj.e900.<\/p>\n

Austin RM, Zhao C (2012). Type 1 and type 2 cervical adenocarcinomas: some cervical cancers are more difficult to prevent with screening. Cytopathology<\/em> 23:6-12.<\/p>\n

Bansal N, Wright JD, Cohen CJ, Herzog TJ (2008). Natural history of established low-grade cervical intraepithelial (CIN1) lesions. Anticancer Res<\/em> 28:1763-6.<\/p>\n

Bray F, Carstensen B, Moller H et al<\/em>. (2005) Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer epidemiol Biomarkers Prev<\/em> 14:2191-9.<\/p>\n

Bulk S, Visser O, Rozendaal L, Verheijen RH, Meijer CJ (2005). Cervical cancer in the Netherlands 1989-1998: decrease of squamous cell carcinoma in older women, increase of adenocarcinoma in younger women. Int J Cancer<\/em> 113:1005-0.<\/p>\n

Carozzi FM, Tomesello ML, Burroni E et al<\/em>. (2010). Prevalence of human papillomavirus types in high-grade cervical intraepithelial neoplasia and cancer in Italy. Cancer Epidemiol Biomarkers Prev<\/em> 19:2389-400.<\/p>\n

Castle PE, Schiffman M, Wheeler CM, Solomon D (2009). Evidence for frequent regression of cervical intraepithelial neoplasia-grade 2. Obstet Gynecol<\/em> 113:18-25.<\/p>\n

Darragh TM, Colgan TJ, Cox JT et al<\/em>. (2012). The lower anogenital squamous terminology standardization project for HPV-associated lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. Arc Pathol Lab Med <\/em>136:1266-97.<\/p>\n

de Sanjose S, Quint WGV, Alemany L et al<\/em>. (2010) Human papillomvirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional survey. Lancet Oncol<\/em> 11:1048-56.<\/p>\n

Galgano MT, Castle PE, Atkins KA et al<\/em>. (2010). Using biomarkers as objective standards in the diagnosis of cervical biopsies. Am J Surg Pathol<\/em> 3:1077-87.<\/p>\n

Gustafsson L, Adami HO (1989). Natural history of cervical neoplasia: consistent results obtained by an identification technique. Br J Cancer<\/em> 60:132-41.<\/p>\n

Herbert A, Anshu, Culora G et al<\/em>. (2010). Invasive cervical cancer audit: why cancers developed in a high-risk population with an organised screening programme. Br J Obstet Gynaecol<\/em> 117:736-45.<\/p>\n

Holowaty P, Miller AB, Rohan T, To T (1999). Natural history of dysplasia of the uterine cervix. J Natl Cancer Inst <\/em>91:252-8.<\/p>\n

Jaisamrarn U, Castellsague X, Garland SM et al<\/em>. (2013). Natural history of HPV infection to cervical lesion or clearance: analysis of the control arm of the large, randomised PATRICIA study. PLoS One 8:e79260.<\/p>\n

Jordan J, Arbyn M, Martin-Hirsch P et al<\/em>. (2008) European guidelines for quality assurance in cervical cancer screening: recommendations for clinical management of abnormal cervical cytology. Cytopathology<\/em> 19:342-54.<\/p>\n

Kelloff GJ, Sigman CC (2007). Assessing intraepithelial neoplasia and drug safety in cancer-preventative drug development. Nature Reviews Cancer <\/em>7:508-18.<\/p>\n

McCredie MR, Sharples KJ, Baranyai J et al<\/em>. (2008) Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial  neoplasia 3: a retrospective cohort study. Lancet Oncol<\/em> 9:425-34.<\/p>\n

Ost\u00f6r AG (1993). Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol <\/em> 12:186-92.<\/p>\n

Ost\u00f6r AG, Duncan A, Quinn M, Rome R (2000). Adenocarcinoma in situ of the uterine cervix: an experience with 100 cases. Gynecol Oncol<\/em> 79:207-10.<\/p>\n

Peto J, Gilham C, Fletcher O, Matthews FE (2004). The cervical cancer epidemic that screening has prevented in the UK. Lancet<\/em> 364:249-56.<\/p>\n

Prendiville W (2009). The treatment of CIN: what are the risks? Cytopathology<\/em> 20:145-53.<\/p>\n

Sasieni P, Castanon A, Cuzick J (2009). Screening and adenocarcinoma. Int J Cancer<\/em> 125:525-9.<\/p>\n

Stoler MH, Schiffman M (2001). Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA<\/em> 285:1500-5.<\/p>\n

Talaat A, Brinkmann D, Dhundee J et al<\/em>. (2012).  Risk of significant gynaecological pathology in women with ?glandular neoplasia on cervical cytology.  Cytopathology<\/em> 23:371-7.<\/p>\n

Viczaino AP, Moreno V, Bosch FX (1998). International trends in the incidence of cervical cancer: adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer<\/em> 75:536-45.<\/p>\n

WHO (2015). World Health Organisation Classification of Tumours. Pathology and genetics of tumours of the breast and female genital organs. IARC 2015. Available from www.iarc.fr\/en\/publications\/pdfs-online\/pat-gen\/bb4\/index.php<\/p>\n

Woodman CJ, Collins C, Rollason TP et al<\/em>. (2003). Human papillomavirus type 18 and rapidly progressing cervical intraepithelial neoplasia.  Lancet<\/em> 2003;361:40-3. <\/p>\n","protected":false},"excerpt":{"rendered":"

Bookmark (0<\/i>)<\/span><\/a>
<\/a>

Please login to bookmark<\/h3>

\n\t\t\t\t

\n\t\t\t\t

\n\t\t\t\t\n\t\t\t\t\n\t\t\t<\/p><\/form>

No account yet? Register<\/a><\/p><\/div><\/div><\/div>

Andrae B, Andersson T M-L, Lambert PC et al. (2012). Screening and cervical cancer cures: population based cohort study. BMJ  e900. Doi: 10.1136\/bmj.e900. Austin RM, Zhao C (2012). Type 1 and type 2 cervical adenocarcinomas: some cervical cancers are more difficult to prevent with screening. Cytopathology 23:6-12. Bansal N, Wright JD, Cohen CJ, Herzog TJ […]<\/p>\n","protected":false},"featured_media":0,"parent":4347,"menu_order":0,"template":"","meta":[],"tags":[],"course_area":[97],"authors":[],"class_list":["post-4396","course","type-course","status-publish","hentry","course_area-cervice"],"yoast_head":"\nReferences - Eurocytology<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"References - Eurocytology\" \/>\n<meta property=\"og:description\" content=\"Andrae B, Andersson T M-L, Lambert PC et al. (2012). Screening and cervical cancer cures: population based cohort study. BMJ  e900. Doi: 10.1136\/bmj.e900. Austin RM, Zhao C (2012). Type 1 and type 2 cervical adenocarcinomas: some cervical cancers are more difficult to prevent with screening. Cytopathology 23:6-12. Bansal N, Wright JD, Cohen CJ, Herzog TJ […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/\" \/>\n<meta property=\"og:site_name\" content=\"Eurocytology\" \/>\n<meta property=\"article:modified_time\" content=\"2023-04-24T08:39:44+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/\",\"url\":\"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/\",\"name\":\"References - Eurocytology\",\"isPartOf\":{\"@id\":\"https:\/\/www.eurocytology.eu\/#website\"},\"datePublished\":\"2023-03-17T08:43:05+00:00\",\"dateModified\":\"2023-04-24T08:39:44+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.eurocytology.eu\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Courses\",\"item\":\"https:\/\/www.eurocytology.eu\/course\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Cervice\",\"item\":\"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/\"},{\"@type\":\"ListItem\",\"position\":4,\"name\":\"4. Patogenesi del carcinoma della cervice\",\"item\":\"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/\"},{\"@type\":\"ListItem\",\"position\":5,\"name\":\"References\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.eurocytology.eu\/#website\",\"url\":\"https:\/\/www.eurocytology.eu\/\",\"name\":\"Eurocytology\",\"description\":\"The Eurocytology project is supported by the Leonardo da Vinci program with the aim of increasing access to training in clinical cytology and of harmonising training in this important specialty of pathology throughout the EU.\",\"publisher\":{\"@id\":\"https:\/\/www.eurocytology.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.eurocytology.eu\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.eurocytology.eu\/#organization\",\"name\":\"Eurocytology\",\"url\":\"https:\/\/www.eurocytology.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.eurocytology.eu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.eurocytology.eu\/wp-content\/uploads\/2023\/02\/logo_white.png\",\"contentUrl\":\"https:\/\/www.eurocytology.eu\/wp-content\/uploads\/2023\/02\/logo_white.png\",\"width\":250,\"height\":76,\"caption\":\"Eurocytology\"},\"image\":{\"@id\":\"https:\/\/www.eurocytology.eu\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"References - Eurocytology","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/","og_locale":"it_IT","og_type":"article","og_title":"References - Eurocytology","og_description":"Andrae B, Andersson T M-L, Lambert PC et al. (2012). Screening and cervical cancer cures: population based cohort study. BMJ  e900. Doi: 10.1136\/bmj.e900. Austin RM, Zhao C (2012). Type 1 and type 2 cervical adenocarcinomas: some cervical cancers are more difficult to prevent with screening. Cytopathology 23:6-12. Bansal N, Wright JD, Cohen CJ, Herzog TJ […]","og_url":"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/","og_site_name":"Eurocytology","article_modified_time":"2023-04-24T08:39:44+00:00","twitter_card":"summary_large_image","twitter_misc":{"Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/","url":"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/","name":"References - Eurocytology","isPartOf":{"@id":"https:\/\/www.eurocytology.eu\/#website"},"datePublished":"2023-03-17T08:43:05+00:00","dateModified":"2023-04-24T08:39:44+00:00","breadcrumb":{"@id":"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/references-4\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.eurocytology.eu\/"},{"@type":"ListItem","position":2,"name":"Courses","item":"https:\/\/www.eurocytology.eu\/course\/"},{"@type":"ListItem","position":3,"name":"Cervice","item":"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/"},{"@type":"ListItem","position":4,"name":"4. Patogenesi del carcinoma della cervice","item":"https:\/\/www.eurocytology.eu\/it\/course\/cervice-2\/4-patogenesi-del-carcinoma-della-cervice\/"},{"@type":"ListItem","position":5,"name":"References"}]},{"@type":"WebSite","@id":"https:\/\/www.eurocytology.eu\/#website","url":"https:\/\/www.eurocytology.eu\/","name":"Eurocytology","description":"The Eurocytology project is supported by the Leonardo da Vinci program with the aim of increasing access to training in clinical cytology and of harmonising training in this important specialty of pathology throughout the EU.","publisher":{"@id":"https:\/\/www.eurocytology.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.eurocytology.eu\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.eurocytology.eu\/#organization","name":"Eurocytology","url":"https:\/\/www.eurocytology.eu\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.eurocytology.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.eurocytology.eu\/wp-content\/uploads\/2023\/02\/logo_white.png","contentUrl":"https:\/\/www.eurocytology.eu\/wp-content\/uploads\/2023\/02\/logo_white.png","width":250,"height":76,"caption":"Eurocytology"},"image":{"@id":"https:\/\/www.eurocytology.eu\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/www.eurocytology.eu\/it\/wp-json\/wp\/v2\/course\/4396","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.eurocytology.eu\/it\/wp-json\/wp\/v2\/course"}],"about":[{"href":"https:\/\/www.eurocytology.eu\/it\/wp-json\/wp\/v2\/types\/course"}],"version-history":[{"count":2,"href":"https:\/\/www.eurocytology.eu\/it\/wp-json\/wp\/v2\/course\/4396\/revisions"}],"predecessor-version":[{"id":4835,"href":"https:\/\/www.eurocytology.eu\/it\/wp-json\/wp\/v2\/course\/4396\/revisions\/4835"}],"up":[{"embeddable":true,"href":"https:\/\/www.eurocytology.eu\/it\/wp-json\/wp\/v2\/course\/4347"}],"wp:attachment":[{"href":"https:\/\/www.eurocytology.eu\/it\/wp-json\/wp\/v2\/media?parent=4396"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.eurocytology.eu\/it\/wp-json\/wp\/v2\/tags?post=4396"},{"taxonomy":"course_area","embeddable":true,"href":"https:\/\/www.eurocytology.eu\/it\/wp-json\/wp\/v2\/course_area?post=4396"},{"taxonomy":"authors","embeddable":true,"href":"https:\/\/www.eurocytology.eu\/it\/wp-json\/wp\/v2\/authors?post=4396"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}